Johnson & Johnson(JNJ) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 7:52 PM ET (Korea 9/12 08:52)
Full metrics table
| Index | DJIA, S&P 500 | P/E | 30.78 | EPS (ttm) | 8.63 | Insider Own | 0.14% | Shs Outstand | 2.41B | Perf Week | -4.62% |
| Market Cap | 640.02B | Forward P/E | 20.78 | EPS next Y | 10.67% | Insider Trans | -7.39% | Shs Float | 2.41B | Perf Month | 1.81% |
| Enterprise Value | 668.30B | PEG | 2.1 | EPS next Q | 2.9 | Inst Own | 77.48% | Short Float | 0.9% | Perf Quarter | 11.43% |
| Income | 21.04B | P/S | 6.53 | EPS this Y | 7.05% | Inst Trans | 0.1% | Short Ratio | 2.81 | Perf Half Y | 9.73% |
| Sales | 97.94B | P/B | 7.53 | EPS next 5Y | 9.88% | ROA | 10.67% | Short Interest | 21.67M | Perf YTD | 28.33% |
| Book/sh | 35.28 | P/C | 30.83 | EPS past 3/5Y | 17.88% 14.9% | ROE | 25.74% | 52W High | -5.51% ($281.07) | Perf Year | 48.78% |
| Cash/sh | 8.61 | P/FCF | 28.77 | Sales past 3/5Y | 5.56% 2.67% | ROIC | 17.2% | 52W Low | 53.22% ($173.33) | Perf 3Y | 63.27% |
| Dividend Est. | $5.38 (2.02%) | EV/EBITDA | 19.55 | EPS Y/Y TTM | -7.21% | Gross Margin | 68.03% | Volatility(W/M) | 1.7% 1.79% | Perf 5Y | 59.06% |
| Dividend TTM | 5.28 | EV/Sales | 6.82 | Sales Y/Y TTM | 8.07% | Oper. Margin | 26.99% | ATR (14) | 5.53 | Perf 10Y | 124.63% |
| Dividend Ex-Date | 2026/8/25 | Quick Ratio | 0.81 | EPS Q/Q | -0.92% | Profit Margin | 21.48% | RSI (14) | 48.54 | Recom | 1.85 |
| Dividend Gr. 3/5Y | 4.92% 5.25% | Current Ratio | 1.09 | Sales Q/Q | 6.64% | SMA20 | -1.43% ($269.43) | Beta | 0.21 | Target Price | $282.1 |
| Payout | 46.59% | Debt/Eq | 0.58 | Earnings | 2026/7/15 | SMA50 | 1.09% ($262.72) | Rel Volume | 0.57 | Prev Close | $266.35 |
| Employees | 140800 | LT Debt/Eq | 0.44 | EPS/Sales Surpr. | 1.59% 0.99% | SMA200 | 12% ($237.12) | Avg Volume(3M) | 7.71M | Price | $265.58 |
| IPO | 1944/9/25 | Option/Short | Yes/Yes | Trades | 84086 | Volume | 4,386,405 | Change | -0.29% |
Company
JNJ is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💊 A global diversified healthcare company operating a two-pillar business structure of innovative pharmaceuticals and medtech (medical devices). Founded in 1886 in New Jersey, USA, it has expanded across the pharmaceuticals and medical devices sectors throughout its long history, and has established itself as a representative US dividend growth stock included in the Dow Jones Industrial Average.
Over the past 1 year, on the higher side
6% below its 1-year high.
JNJ makes money exceptionally well
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +7.0% this year.
Tap to view numbers
The price looks about right
Trading at 30.8 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +63.3% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 2.02% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 77.5%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
IHE 0.22%
TRUH 0.11%
XLV 0.11%
IYH 0.10%
FHLC 0.09%It ranks #2 in the industry
Based on market cap of $640B.
JNJ $640B PER 30.8
LLY $1.1T PER 37.9
ABBV $454B PER 72.7
MRK $355B PER 115.0
FAQ
What kind of company is JNJ?
JNJ belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.
What is the market cap of JNJ?
The market cap of JNJ is approximately $640.0B, ranking 23 within its sector.
Does JNJ pay dividends?
JNJ has a dividend yield of approximately 2.02%, with an annual dividend of $5.38.
What is the P/E ratio of JNJ?
JNJ has a P/E ratio of approximately 30.8x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for JNJ?
JNJ has recorded a 52-week high of $281.07 and a low of $173.33.
